About the Company
We do not have any company description for ELUTIA INC. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on ELUTIA INC.
Analysts Have Been Trimming Their Elutia Inc. (NASDAQ:ELUT) Price Target After Its Latest Report
NasdaqCM:ELUT 1 Year Share Price vs Fair Value Explore Elutia's Fair Values from the Community and select yours ...
Elutia Inc (ELUT) Q2 2025 Earnings Call Highlights: Strong EluPro Growth Amid Financial Challenges
Elutia Inc (ELUT) reports robust EluPro sales growth and strategic partnerships, but faces ongoing financial hurdles and ...
Elutia Inc. Reports Strong Growth and Strategic Advances
Aziyo Biologics, Inc. Class A ( (ELUT) ) has released its Q2 earnings. Here is a breakdown of the information Aziyo Biologics, Inc. Class A presented to its investors.Elevate Your Investing Strategy: ...
Elutia Inc. (NASDAQ:ELUT) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript August 14, 2025 Elutia Inc. misses on earnings expectations. Reported EPS is $-0.26 EPS, expectations were $-0.17. Operator: Good afternoon, ladies and gentlemen.
Elutia Inc. to Release Fourth Quarter and Full Year 2024 ... - Nasdaq
Elutia Inc. has not provided any forward-looking guidance or commentary on the expected performance of its fourth quarter and full year 2024 results, which could lead to investor uncertainty.
Elutia Inc. Announces $15 Million Registered Direct Offering ... - Nasdaq
Elutia Inc. has announced a definitive agreement with investors to sell 5,520,000 shares of its Class A common stock at $2.50 per share and 480,000 prefunded warrants for $2.499 each, which are ...
Elutia Inc. Reports Strong Q3 Results, Prepares for Major Product ...
Elutia Inc., a leader in drug-eluting biomatrix products, focuses on enhancing the compatibility between medical devices and patients, particularly in the field of implantable technologies.
Elutia Inc. (ELUT) latest stock news and headlines – Yahoo Finance
Elutia Celebrates First Year Company Thanks Stakeholders and Employees for a Year of Remarkable Growth and Accomplishment SILVER SPRING, Md., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ...
Elutia, Inc. (ELUT) Q4 2023 Earnings Call Transcript
Elutia, Inc. (NASDAQ:ELUT) Q4 2023 Results Conference Call March 7, 2024 4:30 PM ETCompany ParticipantsMatt Steinberg - Finn PartnersRandy Mills - President ...
Elutia Inc.: Elutia Completes Divestiture of Orthobiologics Business ...
ELUTIA INC WKN: A2QD87|ISIN: US05479K1060|Ticker-Symbol: NASDAQ 12.04.24 22:00 3,010 +0,250+9,06 % Nachrichten Analysen Kurse Chart Branche Biotechnologie Aktienmarkt Sonstige 1-Jahres-Chart 5 ...
Elutia Inc - Ordinary Shares - Class A ELUT Overview - U.S. News
Elutia, Inc. operates as a biotechnology company. It develops biologic products to improve compatibility between medical devices and the patients who need them. The firm operates through the ...
Elutia Inc. (ELUT) Q2 2024 Earnings Call Transcript
Elutia Inc. (NASDAQ: ELUT) Q2 2024 Earnings Conference Call August 7, 2024 4:30 PM ET Company Participants Matt Steinberg - Finn Partners, IR Randy Mills - President and CEO Matt Ferguson - Chief ...
Similar Companies
Loading the latest forecasts...